• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Alexion Pharmaceuticals

Alexion Pharmaceuticals

Alexion Pharmaceuticals Inc ALXN 3 Star

Last Price$160.60Day Change (%)-0.58%
Open Price$161.77Day Change ($)-0.93
Day Range160.45–162.2852-Week Range100.89–185.43

As of Thu 09/18/2014 01:51 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Improved Survival Observed in Pediatric Patients with Severe Hypophosphatasia (HPP) Who Were Treated with Investigational Asfotase Alfa for Up to Five Years

    Improved Survival Observed in Pediatric Patients with Severe Hypophosphatasia (HPP) Who Were Treated with Investigational Asfotase Alfa for Up to Five Years

  2. NICE Recommends Commissioning of Eculizumab (Soliris®) for All Patients with aHUS in England

    NICE Recommends Commissioning of Eculizumab (Soliris®) for All Patients with aHUS in England

  3. Alexion Initiates Multinational Registration Trial of Eculizumab for the Prevention of Delayed Graft Function (DGF) after Kidney Transplantation

    Alexion Initiates Multinational Registration Trial of Eculizumab for the Prevention of Delayed Graft Function (DGF) after Kidney Transplantation

  4. Medalist Funds Like These Large-Cap Stocks

    We crunch the numbers to see which stocks are most widely held among analyst-recommended large-cap funds.

  5. Which Funds Own My Stock?

    Ownership data provide a look at who else owns the company.

  6. Our 5 Nominees for Domestic-Stock Fund Manager of the Year

    Standing out in a good year for stocks.

  7. Morningstar Indexes: Weekly Market Report

    Week ending Nov. 10: Investors remain optimistic about direction of economy.

  8. How to Avoid Unpleasant Surprises

    Buying a country or sector fund isn't as easy as it seems.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.